Overview

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

Status:
Completed
Trial end date:
2018-05-16
Target enrollment:
Participant gender:
Summary
This is a Phase 2b, randomized, double-blind, saline placebo- and active-controlled, multicenter study in subjects undergoing primary unilateral total knee arthroplasty (TKA) to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of HTX-011 administered via infiltration to the surgical site.
Phase:
Phase 2
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Bupivacaine
Epinephrine
Ropivacaine